Innovative clinical study for patients with decompensated cirrhosis

Innovative clinical study for patients with decompensated cirrhosis

He FDI Clinical Research announced today that it is recruiting patients with decompensated cirrhosis to participate in the clinical study of an innovative treatment that seeks to combat the damage caused by this condition.

Decompensated cirrhosis is a chronic and irreversible disease of the liver that can have serious health consequences. Among the complications that may arise are coagulation problems, excessive accumulation of fluid in the abdomen (ascites), bleeding from esophageal varices and hepatic encephalopathy, The research center explains in a statement.

“At FDI Clinical Research we are committed to developing treatments that improve the quality of life of those with decompensated cirrhosis. Our team of researchers is conducting clinical studies that seek to develop therapies that can reverse some of the damage caused by this condition, until now considered irreversible.” explained Dr. Jose Rodriguez Orengo, chief executive officer of FDI Clinical Research, in a press release.

For her part, Dr. Vivian Tamayo, researcher in the study, highlighted the importance of recruiting patients with decompensated cirrhosis to advance in the knowledge and treatment of this disease. “This study represents a unique opportunity to contribute to the advancement of science in the management of decompensated cirrhosis. We are looking for courageous and committed individuals who want to participate in finding innovative solutions for this condition.”

“If you are a person suffering from decompensated cirrhosis, we invite you to consider this valuable opportunity to contribute to medical science. and potentially improve your quality of life. At FDI Clinical Research, we strive to provide a safe environment for our patients, and we guarantee confidentiality and ethics in all of our research,” added Dr. Tamayo in the statement.

People interested in participating in the study should contact FDI Clinical Research at (787) 722-1248.

Kumneger Media
Kumneger Media
Kumneger Media is a News and Entertainment Website & Channel. Kumneger Media in addition to News and Entertainment it is the hub of Politics, Movies, Drama, Music, Comedy, Documentary and More!